Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
Go back to Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 33.79 -1.08 (3.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.87 | 52 Week High | $5.17 | |||
| Open | $34.63 | 52 Week Low | $0.94 | |||
| Day High | $34.81 | P/E | N/A | |||
| Day Low | $33.60 | EPS | $0.00 | |||
| Volume | 847,186 | |||||
